Allo-Mother’s Milk Part I discussed cultural, historical,
and evolutionary perspectives of allo-mother’s milk. Here Allo-Mother’s Milk Part
II continues…
Right now numerous entities are developing a “milk” supply
for clinical intervention. Examples of this endeavor are Prolacta and
the non-profit Human Milk Bank Association of North America. One critically
important application for donor milk is that it reduces the risk of necrotizing entercolitis in NICU babies. A recent meta-analysis of randomized, controlled
trials revealed that premature babies that consumed commercial formula were 4
times more likely to develop this dangerous infection than premature infants
that consumed donor milk (Ben et al. 2012).
These "milk" supply efforts rely on donated milk from women screened for
heath and lifestyle. After donation, milk undergoes processing to make it safer
(e.g. pasteurization). These processes, while important for protecting the
recipient, can also neutralize some of the beneficial bioactive constituents in
milk. Moreover the overhead costs and clinical applications of these milk banks
and commercial entities limit the general public’s access to human milk.
And the
general public is clamoring for raw, unpasteurized human breast milk.
As stated by Geraghty et al. 2011 “A first step in understanding how to
share raw, unpasteurized human milk is simple: just enter key words such as
“breast milk” or “human milk” into an Internet search engine along with another
descriptor such as “buy, purchase, sell, want, for sale, or share.” This action
produces a variety of links to donor milk banks, classified advertisements,
blogs, chat rooms on social networking sites, and random posts.”
I’ll be honest, selling human breast milk -unscreened,
unregulated- on the internet is terrifying to me on numerous levels. Let’s just
set aside my humanist concerns about how the current economic climate induces
women to upregulate milk synthesis to make ends meet, potentially compromising
their own health and their baby’s health. This keeps me awake at night because
of the basic deficits in our fundamental understanding of breast milk.
We don’t know what is in milk.
Yay for Terran Echegoyen-McCabe and Christina Luna!
Although we know that in general milk contains hundreds,
maybe thousands, of bioactive molecules, a systematic description of everything
in human milk does not exist. There are constituents that are
crucial for the infant’s health and development that are not yet in commercial
formulas such as immune factors, oligosaccharides, growth factor, cortisol, and
beneficial bacteria. This is why people are keen to buy breast milk, and willing to go online to do so.
But in terms of buying milk from faceless strangers on the
internet, we have no idea what is in that specific milk. Milk can include
viruses, pathogenic bacteria, drugs, and poisonous toxins. HIV, E. coli, and meth are rare and the
probability that they are the milk being traded online is slim, but its not zero. If I was at the hospital and I had
a choice between
Bag A and Bag B for my blood transfusion, and Bag A definitely didn’t have HIV
or meth, and Bag B probably didn’t, guess which bag I'd choose. I certainly
wouldn't say "Let's have my lucky quarter decide- heads, Bag A and tails,
Bag B!"
And lots of potentially dangerous things in milk aren't quite so
rare- such as BPA, cytomegalovirus, and over-the-counter drugs.
Moreover
the value of human breast milk is by volume. The composition can not be
evaluated by the consumer. Now, I expect that most people are likely providing healthy, safe milk via the internet. But just as some unscrupulous drug dealers cut cocaine
with talcum powder, internet milk may be padded with cow’s milk or tap water. At least the drug dealer has some
incentive to not sell weak blow. The drug dealer wants to keep customers coming
back- and not to kick his ass. Those constraints don’t apply to people selling
human milk on the internet. The benefit of cheating is very high, the risk of
getting caught is very low, and the consequences if caught are NOTHING.
We don’t know how or why milk constituents vary.
Studies have shown that concentrations of constituents in
milk vary across lactation within mother or among mothers at any given time,
but we don’t entirely know how much or why (Hinde & Milligan 2011). Sure, we
know that colostrum is different than mature milk, but that’s a simple
dichotomy. This isn’t the bulk candy aisle where mixing and matching gummy
worms and chocolate covered pretzels provides the perfect synthesis of savory
and sweet.
Across infancy there are critical windows of metabolomic,
neurobiological, skeletal, and physiological development. Sometimes there are
do-overs and catch up, but sometimes there isn’t. The functional development of
the mammary occurs during pregnancy when a woman’s placenta and fetus can
hormonally signal to her mammary gland. For this reason scientists hypothesize
that the milk a mother synthesizes is specific to her infant precisely at that
time, linked to that infant’s developmental trajectory and her own condition. Although there may be benefits to allo-mother's milk from an evolutionary perspective, when observed in other mammals allo-mother's milk supplements mother's milk, its not usually a replacement.
We don’t know what all these constituents do in the baby.
That’s
right, I said it.
Lovely Adelaide
We.
Don’t. Know.
There are relatively few studies that look at the
consequences for the infant as a result of variation in the concentration of
milk constituents and milk volume among mothers. Fortunately, this area of
research is expanding due to new assay methods and renewed
intellectual interest in inter-individual differences. Milk is the new British
Empire- the sun never sets on lactation science. Dairy milk is a leading global
industry and unlocking the fundamentals of mammary gland biology is critical
for cancer research. If we had all the answers to milk- the sum total of what
it is and what it does- that would be fantastic. But research takes money and time, especially when studying
incredibly complex humans who develop slowly.
And in the meantime, I can swing over to Only the Breast, browse
the profiles of women and photos of their robust babies, and buy "liquid gold" for
$2/oz.
So
what is the solution?
Obviously
we have to tip the scales of supply and demand.
Goal
#1: Reduce the Demand for “Grey” Market Human Breast Milk
RISK
AWARENESS Solution: Effectively communicate the risks and
dangers of purchasing unscreened human breast milk from strangers. One way to
do that would be to… oh… I don’t know… hows about you forward this blog post?
IMPROVED
FORMULA Solution: Parents who want to feed their baby
breast milk, but for whatever reason can't, are buying internet milk because they don’t want to use
formula. If a more representative formula were available (cost effectively), its likely that fewer
parents would take the risk of internet breast milk. Commercial infant formulas
need to better reflect the complex biofluid that is human milk. Advantageously, many
companies are interested in doing just that. Commercial formula R&D teams
are actively translating new data on mother’s milk into food science.
Goal
#2: Increase the Supply of Breast Milk
MORE
HUMAN MILK Solution: Expand the current national network of
milk banks, donor programs, and private industry similar to the management of
our national blood supply. (American Red Cross… I am looking in your direction).
Just as many hands make light work, many boobs produce substantial volumes of
life-saving donor milk, at low per individual cost. This would generate a
larger supply of donor milk, increase screening of donated milk, and
standardize “best practices” for collection and storage. Such a plan would have
to guard against potential problems of the commercialization of human fluids
(very tricky). It would also require the improvement of processing techniques so as
to retain the bioactivity of milk constituents. Most importantly, the products
of these efforts can not be restricted exclusively to clinical settings like the NICU. We
must find a way to make them safely and economically available to the general
public.
The solutions outlined above are contingent on fundamental
milk science research. We can’t communicate the specific risks without broadly surveying
milk composition across women. Similarly, infant formula can’t be improved
without a better understanding of how bioactive constituents in milk affect babies.
Lastly, we need to optimize milk processing techniques to maximize safety
without neutralizing important bioactive constituents. Research of this
magnitude requires substantial investment in the form of research grants, but
the benefits to human health and nutrition are substantial.
The US
Department of Health and Human Services oversees the National Institutes of
Health, the leading funders of human health research in the US. Currently, Strategic Initiatives of the DHHS include the goals to:
-Promote
Early Childhood Health and Development
-Implement
a 21st Century Food Safety System
-Accelerate
the Process of Scientific Discovery To Improve Patient Care
Breast milk,
and the online trading of it, has implications for all of these initiatives. If
these topics matter to you and you think funding research on mother's milk is important,
I encourage you to contact DHHS Secretary Sebelius and/or your senators and representatives in Congress.
References:
Ben
et al. 2012. The Benefits of Expressed Maternal Milk and Donor Breast Milk for
Preventing Necrotizing Enterocolitis in Preterm Infants: Systematic Review and
Meta-Analysis. J Nutrition Disorder Ther 2:2 doi.org/10.4172/jndt.1000110
Geraghty,
Heier, & Rasmussen. 2011. Got milk? Sharing human milk via the Internet. Public
Health Rep. 126:161-4.
Hinde
& Milligan. 2011. Primate milk: proximate mechanisms and ultimate
perspectives. Evol Anthropol. 20:9-23
And naturally just as I finished writing this post I discovered a kickass article over at Slate.

















